Systemic Lupus Erythematosus

Henry Ford Health System – Rheumatology
Primary Coordinator: Jenna Hudy 313-916-9328

  • Indication: Systemic Lupus Erythematosus
  • Enrollment Status: Open
  • Protocol: CA061-1001
  • Drug: CAR-T
  • Sponsor: Bristol Meyers Squibb
  • Description: A Phase 1 Study of CC-97540 in Severe, Refractory Autoimmune Diseases: Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathy (IIM) or Systemic Sclerosis (SSc)

Returning Member? Please login to check membership status!